Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Biomolecules & Therapeutics ; : 659-664, 2016.
Article in English | WPRIM | ID: wpr-209966

ABSTRACT

Lindera obtusiloba has been used in traditional herbal medicine for the treatment of blood stasis and inflammation. The leaves of Lindera obtusiloba have been reported to exhibit various physiological activities. However, there is little information available on their antiplatelet and antithrombotic activities. Thus, the present study aimed to evaluate the effect of Lindera obtusiloba leaf extract (LLE) on platelet activities, coagulation and thromboembolism. In a platelet aggregation study, LLE significantly inhibited various agonist-induced platelet aggregations in vitro and ex vivo. Furthermore, LLE significantly inhibited collagen-induced thromboxane A2 (TXA2) production in rat platelets. In addition, oral administration of LLE was protective in a mouse model of pulmonary thromboembolism induced by intravenous injection of a mixture of collagen and epinephrine. Interestingly, LLE did not significantly alter prothrombin time (PT) and activated partial thromboplastin time (aPTT). This study indicates that the antithrombotic effects of LLE might be due to its antiplatelet activities rather than anticoagulation. Taken together, these results suggest that LLE may be a candidate preventive and therapeutic agent in cardiovascular diseases associated with platelet hyperactivity.


Subject(s)
Animals , Mice , Rats , Administration, Oral , Blood Platelets , Cardiovascular Diseases , Collagen , Epinephrine , Herbal Medicine , In Vitro Techniques , Inflammation , Injections, Intravenous , Lindera , Partial Thromboplastin Time , Platelet Aggregation , Prothrombin Time , Pulmonary Embolism , Thromboembolism , Thrombosis , Thromboxane A2
3.
The Korean Journal of Physiology and Pharmacology ; : 237-241, 2012.
Article in English | WPRIM | ID: wpr-728094

ABSTRACT

In this study, we determined mode of action of a novel carbamoyloxy arylalkanoyl arylpiperazine compound (SKL-NP) on hyperpolarization-activated cyclic nucleotide-gated (HCN) channel currents (Ih) that plays important roles in neuropathic pain. In small or medium-sized dorsal root ganglion (DRG) neurons (<40 microm in diameter) exhibiting tonic firing and prominent Ih, SKL-NP inhibited Ih and spike firings in a concentration dependent manner (IC50=7.85 microM). SKL-NP-induced inhibition of Ih was blocked by pretreatment of pertussis toxin (PTX) and N-ethylmaleimide (NEM) as well as 8-Br-cAMP, a membrane permeable cAMP analogue. These results suggest that SKL-NP modulates Ih in indirect manner by the activation of a Gi-protein coupled receptor that decreases intracellular cAMP concentration. Taken together, SKL-NP has the inhibitory effect on HCN channel currents (I h) in DRG neurons of rats.


Subject(s)
Animals , Rats , Diagnosis-Related Groups , Ethylmaleimide , Fires , Ganglia, Spinal , Membranes , Neuralgia , Neurons , Pertussis Toxin , Spinal Nerve Roots
SELECTION OF CITATIONS
SEARCH DETAIL